1. Home
  2. NUVL
  3. NUVL News

Latest Nuvalent Inc. (NUVL) News on September 18, 2025

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

PR Newswire

11 days ago

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

MT Newswires

a year ago

Top Midday Gainers

Share on Social Networks: